title: Isoprostane levels in lipids extracted from atherosclerotic arteries of nonhuman primates.
abstract: Nonhuman primates used in these studies had been fed for 5 years diets enriched with cholesterol and one of three classes of fatty acids: saturated, monounsaturated, or polyunsaturated fatty acids. Atherosclerotic iliac artery lipid extracts were quantitatively analyzed for cholesterol, cholesteryl esters, fatty acid composition, and a marker of lipid oxidation, the F(2)-isoprostanes. There was no significant difference in the mean accumulation of F(2)-isoprostanes among the different diet groups. To account for the small, individual variation in the arachidonate concentration the F(2)-isoprostane mass from each sample was normalized by dividing by arachidonate mass: F(2)-isoprostane mass/(mass arachidonate). At lower levels of cholesterol accumulation, the F(2)-isoprostane mass/(mass arachidonate) ratio was greater in lipids from POLY arteries compared to SAT arteries, but the reverse was true at high levels of cholesterol. F(2)-isoprostane/(mass arachidonate) increased with mole fraction linoleate for the SAT group, but decreased for the POLY group. In summary, these studies demonstrated that there is no simple explanation of how F(2)-isoprostane accumulation did not depend on the concentration of oxidizable lipids that promote free-radical lipid oxidation.
authors.affiliation: Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1016, USA. mthomas@wfubmc.edu
authors.forename: M J
authors.initials: MJ
authors.lastname: Thomas
authors.forename: Q
authors.initials: Q
authors.lastname: Chen
authors.forename: M G
authors.initials: MG
authors.lastname: Sorci-Thomas
authors.forename: L L
authors.initials: LL
authors.lastname: Rudel
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000032:analysis; D001161:Arteriosclerosis / Q000378:metabolism*; D002522:Chlorocebus aethiops; D002784:Cholesterol / Q000032:analysis; D002788:Cholesterol Esters / Q000032:analysis; D008078:Cholesterol, LDL / Q000097:blood; D004036:Diet, Atherogenic; D004041:Dietary Fats / Q000494:pharmacology*; D015237:Dinoprost / Q000032:analysis*; D005227:Fatty Acids / Q000494:pharmacology*; D005609:Free Radicals; D007083:Iliac Artery / Q000737:chemistry; D019787:Linoleic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008055:Lipids / Q000737:chemistry*; D019301:Oleic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D010084:Oxidation-Reduction; D000073878:Palm Oil; D010938:Plant Oils / Q000008:administration & dosage / Q000494:pharmacology; D012450:Safflower Oil / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D001095:Arachidonic Acids; D002788:Cholesterol Esters; D008078:Cholesterol, LDL; D004041:Dietary Fats; D005227:Fatty Acids; D005609:Free Radicals; D008055:Lipids; D010938:Plant Oils; D019301:Oleic Acid; D000073878:Palm Oil; D012450:Safflower Oil; D002784:Cholesterol; D019787:Linoleic Acid; D015237:Dinoprost